Gradually increasing doses of clomiphene, then U/S, reduce time to ovulation, may improve ovulation rate in PCOS women.
Treatment consisting of gradually increasing doses of clomiphene followed by ultrasound is effective in reducing the time to ovulation and often improves the ovulation rate in women with polycystic ovarian syndrome (PCOS) who do not respond to lower doses of the drug, according to a study in the May issue of the American Journal of Obstetrics and Gynecology.
Bradley S. Hurst, MD, and colleagues from Carolinas Medical Center in Charlotte, NC, retrospectively analyzed whether a "stair-step" clomiphene protocol was effective in women with PCOS who did not respond to 50 mg of clomiphene. The protocol consisted of increases in clomiphene dose from 50 mg to 100 mg and 150 mg if the woman remained unresponsive, with each increase in dose followed by ultrasonography.
The researchers found that the stair-step protocol reduced the time to ovulation by 32 to 53 days compared with traditional clomiphene dosing. The ovulation rate was significantly higher for the stair-step protocol at a clomiphene dose of 100 mg compared with the expected rate for this dose with a traditional regimen (64% vs. 2%). However, the clinical pregnancy rate was similar for the two groups (13% vs. 15%).
Hurst BS, Hickman JM, Matthews ML, et al. Novel clomiphene “stair-step” protocol reduces time to ovulation in women with polycystic ovarian syndrome. Am J Obstet Gynecol. 200:510.e1-510.e4.
Chemoattractants in fetal membranes enhance leukocyte migration near term pregnancy
November 22nd 2024A recent study highlights the release of chemoattractants from human fetal membranes at term, driving leukocyte activation and migration, with implications for labor and postpartum recovery.
Read More
Reproductive genetic carrier screening: A tool for reproductive decision-making
November 22nd 2024A new study highlights the efficacy of couple-based reproductive genetic carrier screening in improving reproductive decisions and outcomes, emphasizing its growing availability and acceptance among diverse populations.
Read More
Early preterm birth risk linked to low PlGF levels during pregnancy screening
November 20th 2024New research highlights that low levels of placental growth factor during mid-pregnancy screening can effectively predict early preterm birth, offering a potential tool to enhance maternal and infant health outcomes.
Read More